Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-050086
Filing Date
2012-09-07
Accepted
2012-09-07 13:07:16
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v323283_10qa.htm 10-Q/A 25737
  Complete submission text file 0001144204-12-050086.txt   2162330

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT iccc-20120630.xml EX-101.INS 254887
3 XBRL TAXONOMY EXTENSION SCHEMA iccc-20120630.xsd EX-101.SCH 30057
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20120630_cal.xml EX-101.CAL 37838
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20120630_def.xml EX-101.DEF 117990
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20120630_lab.xml EX-101.LAB 219484
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20120630_pre.xml EX-101.PRE 159347
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-12934 | Film No.: 121079266
SIC: 2835 In Vitro & In Vivo Diagnostic Substances